The effects of SCH 23390, a selective D1 receptor antagonist, injected into either the dorsal striatum or nucleus accumbens on methamphetamine-induced stereotyped gnawing and hyperlocomotion in rats were investigated. SCH 23390 injected into the dorsal striatum did not alter the gnawing induced by both methamphetamine and apomorphine. However, SCH 23390 injected into the nucleus accumbens significantly reduced methamphetamine-induced gnawing without altering the effects of apomorphine. Injection of SCH 23390 into the nucleus accumbens reduced the hyperlocomotion produced by methamphetamine more markedly than injection of SCH 23390 into the dorsal striatum.
The effects of SCH 23390, a selective D1 receptor antagonist, injected into either the dorsal striatum or nucleus accumbens on methamphetamine-induced stereotyped gnawing and hyperlocomotion in rats were investigated. SCH 23390 injected into the dorsal striatum did not alter the gnawing induced by both methamphetamine and apomorphine. However, SCH 23390 injected into the nucleus accumbens significantly reduced methamphetamine-induced gnawing without altering the effects of apomorphine. Injection of SCH 23390 into the nucleus accumbens reduced the hyperlocomotion produced by methamphetamine more markedly than injection of SCH 23390 into the dorsal striatum.
Sulpiride, a specific dopamine 2 (D2) receptor antagonist, has been reported to potentiate apomorphine-and methamphetamine-induced oral stereotypy when injected into the dorsal striatum [1] [2] [3] [4] . A small but significant increase of apomorphine-induced oral stereotypy has also been reported upon injection of a specific D1 receptor antagonist, SCH 23390, into the same site [2] . However, the effect of D1 receptor blockade in the dorsal striatum on methamphetamine-induced oral stereotypy is not known. The present study sought to determine whether injection of SCH 23390 into the dorsal striatum potentiates methamphetamine-induced oral stereotypy. To support the regional differences in function within the areas of dopaminergic neuron terminals, SCH 23390 was also injected into another dopaminergic terminal area, the nucleus accumbens. Hyperlocomotion produced by methamphetamine after intracerebral injection of SCH 23390 was also measured to test the hypothesis that the nucleus accumbens more effectively generates methamphetamine-induced hyperlocomotion via D1 (as well as D2[3]) receptors than the striatum. 
Behavioral methods
To observe behavior, pairs of rats were placed in rectangular activity boxes start of the experiment. The rats received intraperitoneal injections of either methamphetamine (5 or 10mg/kg) or apomorphine (1 or 2mg/kg) 10min after the intracerebral injection. Gnawing behavior was observed for 5 min every 15 min for 1.5 h. The numbers of rats showing continuous gnawing during each observation period were expressed as percentages of the total. To facilitate observation, the cages were raised on 30-cm legs and the animals were viewed from below. For the measurement of locomotor activity, rats were placed singly in experimental boxes 1 h before the start of the experiment. Methamphetamine (3 mg/kg) was injected i. p. 10 min after intracerebral injection of either SCH 23390 or saline, and locomotor activity was measured with a battery of infra-red photocells (Opto-Varimex, Columbus Instruments Ltd.) for 1.5 h.
The drugs used were methamphetamine HCl (Dainippon Pharmaceutical Co. Ltd.), apomorphine HCl (Sigma) and SCH 23390 (Schering Co.).
Statistical analysis
The results from the locomotor experiments were analyzed by two-tailed Student's t test and the gnawing data were analyzed by Fisher's exact probability test.
Effects of intracerebral SCH23390 on methamphetamine-induced gnawing
Only a few (6-11%) of the rats previously injected (10 min before) with saline into the dorsal striatum displayed stereotyped gnawing after methamphetamine (5 injected into the dorsal striatum instead of saline did not alter the gnawing after methamphetamine (Fig.1) . Methamphetamine (10 mg/kg) caused stereotyped gnawing in rats previously injected with saline into the nucleus accumbens. The percentages of rats exhibiting gnawing were between 63% and 79% from 45 to 90 min after methamphetamine injection. This gnawing was significantly (P<0.05) accumbens at 45 and 60 min after methamphetamine injection (Fig.2) 0.05) the locomotor activity produced by methamphetamine (3 mg/kg) from 80 to 90 min after methamphetamine injection (Fig. 3) SCH 23390 injected into the dorsal striatum did not facilitate gnawing induced by either methamphetamine (5 mg/kg) or apomorphine (1 mg/kg). Facilitatory effects of sulpiride injected into the same site on gnawing induced by methamphetamine and apomorphine suggested the importance of D2 (but not D1) receptor blockade in the dorsal striatum [4] . However, a small increase of apomorphineinduced oral stereotypy has also been reported by D1 receptor blockade with SCH 23390 in the dorsal striatum[2]. Our results contradict those of the latter study [2] , which suggested the involvement of D1 (as well as D2) receptor blockade in the dorsal striatum on apomorphine-induced oral stereotypy. The discrepancy between our results and those of the other authors may be partly due to differences in experimental conditions such as the dose employed, and method used for assessing the stereotyped gnawing.
SCH 23390 injected into the nucleus accumbens inhibited methamphetamineinduced gnawing but did not significantly affect the gnawing induced by apomorphine. 
